THIS SITE IS FOR UK MIGRAINE PATIENTS WHO HAVE BEEN PRESCRIBED VYEPTI® (EPTINEZUMAB)

Report an adverse drug reaction

At Lundbeck, we acknowledge our responsibility to patients who depend on our products and knowledge to manage their health condition. Reporting of Adverse Events (AEs) or side effects by healthcare professionals and patients is important in order for us to continuously evaluate the benefits and risks of our medicines.

An Adverse Event (AE) or side effect is an unwanted and unintended effect of a medicinal product experienced by a patient. All medicinal products have potential side effects and could also have potential
unexpected benefits.

At Lundbeck, we continuously monitor the safety and quality of our products to safeguard the people who depend on taking them.

If you experience any side effects, please talk to your doctor, pharmacist, or nurse for advice. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the email address provided below. By reporting side effects, you can help provide more information on the safety of this medicine.

The information you provide helps to ensure the safety of our products and ultimately patients.

Report adverse drug reaction

If you wish to report an adverse drug reaction, side-effect or other safety issue with Vyepti or another Lundbeck product, please forward your message to SafetyLuUnitedKingdom@lundbeck.com or telephone 01908 638972. You may also use use the online contact form by clicking below.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.